Phase I Complexity a Hot Topic at DIA 2008
Attempting to gain early efficacy data and examining possible biomarkers in intent-to-treat patients in phase I trials has become more commonplace as sponsors attempt to fill their thinning pipelines.
Four Clinical Research Innovators Create Consortium in Massachusetts
Four organizations involved in clinical research have joined together to create the Clinical Research Consortium of Massachusetts (CRCM), a cooperative enterprise that supports knowledge and technology transfer between Massachusetts and other international regions interested in building clinical research centers of excellence. The group’s first work is with the Lombardia region of Italy.
Other breaking news...
Company Profile: An interview with Neil Rotherham, executive chairman, and Patrick Hughes, senior VP of strategic business development, Good Products.
To read the full articles for this issue or for more information on these and other breaking stories, please click here for subscription information.